FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3187996904> ?p ?o ?g. }

• W3187996904 endingPage "9" @default.
• W3187996904 startingPage "1" @default.
• W3187996904 abstract "Introduction. Acute-on-chronic liver failure (ACLF) is an acute liver decompensation in cirrhotic patients, which leads to organ failures and high short-term mortality. The treatment is based on the management of complications and, in severe cases, liver transplantation. Since specific treatment is unavailable, we aimed to evaluate the safety and initial efficacy of bone marrow mesenchymal stem cells (BM-MSC) in patients with ACLF Grades 2 and 3, a population excluded from previous clinical trials. Methods. This is a randomized placebo-controlled phase I-II single center study, which enrolled 9 cirrhotic patients from 2018 to 2020, regardless of the etiology. The control group (n = 5) was treated with standard medical therapy (SMT) and placebo infusion of saline. The intervention group (n = 4) received SMT plus 5 infusions of 1 × 106 cells/kg of BM-MSC for 3 weeks. Both groups were monitored for 90 days. A Chi-square test was used for qualitative variables, and the t-test and Mann–Whitney U test for quantitative variables. The Kaplan–Meier estimator was used to build survival curves. In this study, we followed the intention-to-treat analysis, with a significance of 5%. Results. Nine patients with a mean Child–Pugh (CP) of 12.3, MELD of 38.4, and CLIF-C score of 50.7 were recruited. Hepatitis C and alcohol were the main etiologies. The average infusion per patient was 2.9 and only 3 patients (2 in control and 1 in the BM-MSC group) received all the protocol infusions. There were no infusion-related side effects, although one patient in the intervention group presented hypernatremia and a gastric ulcer, after the third and fifth infusions, respectively. The survival rate after 90 days was 20% (1/5) for placebo versus 25% (1/4) for the BM-MSC. The patient who completed the entire MSC protocol showed a significant improvement in CP (C-14 to B-9), MELD (32 to 22), and ACLF (grade 3 to 0). Conclusion. BM-MSC infusion is safe and feasible in patients with ACLF Grades 2 and 3." @default.
• W3187996904 created "2021-08-16" @default.
• W3187996904 creator A5037830101 @default.
• W3187996904 creator A5069563156 @default.
• W3187996904 creator A5086084445 @default.
• W3187996904 creator A5088768773 @default.
• W3187996904 date "2021-08-04" @default.
• W3187996904 modified "2023-10-16" @default.
• W3187996904 title "Bone Marrow Mesenchymal Stem Cells in Acute-on-Chronic Liver Failure Grades 2 and 3: A Phase I-II Randomized Clinical Trial" @default.
• W3187996904 cites W1601443082 @default.
• W3187996904 cites W1984180661 @default.
• W3187996904 cites W1985985259 @default.
• W3187996904 cites W2007536176 @default.
• W3187996904 cites W2007670274 @default.
• W3187996904 cites W2008648354 @default.
• W3187996904 cites W2025371271 @default.
• W3187996904 cites W2030748531 @default.
• W3187996904 cites W2035840561 @default.
• W3187996904 cites W2066275563 @default.
• W3187996904 cites W2076994418 @default.
• W3187996904 cites W2088488647 @default.
• W3187996904 cites W2092885226 @default.
• W3187996904 cites W2104554139 @default.
• W3187996904 cites W2111368337 @default.
• W3187996904 cites W2118765712 @default.
• W3187996904 cites W2128235475 @default.
• W3187996904 cites W2139223251 @default.
• W3187996904 cites W2142907317 @default.
• W3187996904 cites W2143119387 @default.
• W3187996904 cites W2162940124 @default.
• W3187996904 cites W2259810790 @default.
• W3187996904 cites W2376759226 @default.
• W3187996904 cites W2525702703 @default.
• W3187996904 cites W2537698388 @default.
• W3187996904 cites W2547429997 @default.
• W3187996904 cites W2560581251 @default.
• W3187996904 cites W2591717855 @default.
• W3187996904 cites W2598848210 @default.
• W3187996904 cites W2619379016 @default.
• W3187996904 cites W2757323602 @default.
• W3187996904 cites W2759771152 @default.
• W3187996904 cites W2795408572 @default.
• W3187996904 cites W2914062154 @default.
• W3187996904 cites W2942717973 @default.
• W3187996904 cites W2955154756 @default.
• W3187996904 cites W4211190027 @default.
• W3187996904 doi "https://doi.org/10.1155/2021/3662776" @default.
• W3187996904 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8357501" @default.
• W3187996904 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34395335" @default.
• W3187996904 hasPublicationYear "2021" @default.
• W3187996904 type Work @default.
• W3187996904 sameAs 3187996904 @default.
• W3187996904 citedByCount "20" @default.
• W3187996904 countsByYear W31879969042021 @default.
• W3187996904 countsByYear W31879969042022 @default.
• W3187996904 countsByYear W31879969042023 @default.
• W3187996904 crossrefType "journal-article" @default.
• W3187996904 hasAuthorship W3187996904A5037830101 @default.
• W3187996904 hasAuthorship W3187996904A5069563156 @default.
• W3187996904 hasAuthorship W3187996904A5086084445 @default.
• W3187996904 hasAuthorship W3187996904A5088768773 @default.
• W3187996904 hasBestOaLocation W31879969041 @default.
• W3187996904 hasConcept C126322002 @default.
• W3187996904 hasConcept C141071460 @default.
• W3187996904 hasConcept C142724271 @default.
• W3187996904 hasConcept C168563851 @default.
• W3187996904 hasConcept C204787440 @default.
• W3187996904 hasConcept C27081682 @default.
• W3187996904 hasConcept C2777214474 @default.
• W3187996904 hasConcept C2779609443 @default.
• W3187996904 hasConcept C2780007613 @default.
• W3187996904 hasConcept C2908647359 @default.
• W3187996904 hasConcept C2911091166 @default.
• W3187996904 hasConcept C71924100 @default.
• W3187996904 hasConcept C90924648 @default.
• W3187996904 hasConcept C99454951 @default.
• W3187996904 hasConceptScore W3187996904C126322002 @default.
• W3187996904 hasConceptScore W3187996904C141071460 @default.
• W3187996904 hasConceptScore W3187996904C142724271 @default.
• W3187996904 hasConceptScore W3187996904C168563851 @default.
• W3187996904 hasConceptScore W3187996904C204787440 @default.
• W3187996904 hasConceptScore W3187996904C27081682 @default.
• W3187996904 hasConceptScore W3187996904C2777214474 @default.
• W3187996904 hasConceptScore W3187996904C2779609443 @default.
• W3187996904 hasConceptScore W3187996904C2780007613 @default.
• W3187996904 hasConceptScore W3187996904C2908647359 @default.
• W3187996904 hasConceptScore W3187996904C2911091166 @default.
• W3187996904 hasConceptScore W3187996904C71924100 @default.
• W3187996904 hasConceptScore W3187996904C90924648 @default.
• W3187996904 hasConceptScore W3187996904C99454951 @default.
• W3187996904 hasLocation W31879969041 @default.
• W3187996904 hasLocation W31879969042 @default.
• W3187996904 hasLocation W31879969043 @default.
• W3187996904 hasLocation W31879969044 @default.
• W3187996904 hasOpenAccess W3187996904 @default.
• W3187996904 hasPrimaryLocation W31879969041 @default.
• W3187996904 hasRelatedWork W2003938723 @default.
• W3187996904 hasRelatedWork W2047967234 @default.

• next